Breaking News Instant updates and real-time market news.

AMGN

Amgen

$237.10 /

+0.29 (+0.12%)

, FATE

Fate Therapeutics

$75.38 /

+2.62 (+3.60%)

11:25
06/07/21
06/07
11:25
06/07/21
11:25

Cantor biotech/biopharma analysts hold an analyst/industry conference call

Biotechnology Analyst Young & Biopharma Analyst Chen, along with KOL Dr. Sabari, Assistant Professor at NYU Langone Medical Center & Dr. Mehta, Physician at Dana-Farber Cancer Institute, discuss novel treatments for lung and breast cancer, as announced at ASCO Annual Virtual Meeting, on an Analyst/Industry conference call to be held on June 7 at 12 pm.

AMGN

Amgen

$237.10 /

+0.29 (+0.12%)

FATE

Fate Therapeutics

$75.38 /

+2.62 (+3.60%)

GILD

Gilead

$67.47 /

+0.05 (+0.07%)

KDMN

Kadmon

$4.06 /

+0.2 (+5.18%)

PBYI

Puma Biotechnology

$11.76 /

+0.48 (+4.26%)

RCUS

Arcus Biosciences

$25.29 /

+0.16 (+0.64%)

REGN

Regeneron

$516.17 /

+5.34 (+1.05%)

JNJ

Johnson & Johnson

$165.82 /

-0.14 (-0.08%)

PFE

Pfizer

$39.42 /

+0.28 (+0.72%)

MRK

Merck

$73.44 /

-0.68 (-0.92%)

LLY

Eli Lilly

$218.17 /

+16.055 (+7.94%)

IMAB

I-Mab

$75.98 /

-2.02 (-2.59%)

HCM

Hutchmed

$30.80 /

+0.72 (+2.39%)

HTBX

Heat Biologics

$6.80 /

+0.355 (+5.51%)

  • 07

    Jun

  • 07

    Jun

  • 07

    Jun

  • 07

    Jun

  • 11

    Jun

  • 11

    Jun

  • 15

    Jun

  • 16

    Jun

  • 23

    Jun

  • 18

    Jul

  • 21

    Jul

  • 29

    Jul

  • 16

    Aug

  • 30

    Aug

  • 15

    Sep

  • 21

    Oct

  • 28

    Nov

  • 19

    Dec

  • 21

    Dec

  • 29

    Dec

  • 09

    Jun

  • 06

    Jan

  • 13

    Jan

  • 09

    Feb

AMGN Amgen
$237.10 /

+0.29 (+0.12%)

06/07/21 SVB Leerink
Amgen price target raised to $238 from $230 at SVB Leerink
06/07/21 Oppenheimer
Amgen price target raised to $277 from $272 at Oppenheimer
05/31/21 BMO Capital
Amgen price target raised to $301 from $296 at BMO Capital
05/28/21 Piper Sandler
Piper says Amgen's Lumakras approved early, priced a bit lower than expected
FATE Fate Therapeutics
$75.38 /

+2.62 (+3.60%)

06/07/21 H.C. Wainwright
Fate Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
06/04/21 Roth Capital
Fate Therapeutics duration response remains unknown, says Roth Capital
06/04/21 Piper Sandler
Fate's Phase I data showed 8 patients achieved ORR, says Piper Sandler
04/26/21 Jefferies
Fate Therapeutics assumed with a Buy at Jefferies
GILD Gilead
$67.47 /

+0.05 (+0.07%)

04/01/21
Fly Intel: Top five analyst upgrades
04/01/21 Bernstein
Gilead upgraded to Outperform from Market Perform at Bernstein
03/30/21 Redburn
Gilead upgraded to Buy from Neutral at Redburn
03/15/21 Mizuho
Merck's Gilead collaboration likely to broaden reach of islatravir, says Mizuho
KDMN Kadmon
$4.06 /

+0.2 (+5.18%)

06/04/21 Mizuho
Kadmon's KD022 results a positive start for immuno-oncology program, says Mizuho
05/20/21 UBS
Kadmon initiated with a Buy at UBS
03/11/21 Oppenheimer
Kadmon should be bought on weakness from FDA extension, says Oppenheimer
02/10/21 Jefferies
Survey points to 'encouraging' signs for Kadmon's belumosudil, says Jefferies
PBYI Puma Biotechnology
$11.76 /

+0.48 (+4.26%)

12/24/20 Craig-Hallum
Celcuity price target raised to $19 from $16 at Craig-Hallum
06/25/20 BofA
Puma Biotechnology reinstated with an Underperform at BofA
06/25/20 BofA
Puma Biotechnology initiated with an Underperform at BofA
RCUS Arcus Biosciences
$25.29 /

+0.16 (+0.64%)

02/25/21 Barclays
Arcus Biosciences price target raised to $45 from $40 at Barclays
02/25/21 Mizuho
Arcus Biosciences price target raised to $43 from $40 at Mizuho
01/20/21 Citi
Arcus Biosciences price target raised to $51 from $32 at Citi
01/19/21 Wedbush
Arcus Biosciences price target raised to $55 from $48 at Wedbush
REGN Regeneron
$516.17 /

+5.34 (+1.05%)

05/13/21 Needham
Graybug Vision downgraded to Hold from Buy at Needham
05/07/21 Morgan Stanley
Regeneron price target raised to $495 from $477 at Morgan Stanley
05/06/21 Piper Sandler
Regeneron remains top large cap pick, says Piper Sandler
04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
JNJ Johnson & Johnson
$165.82 /

-0.14 (-0.08%)

06/02/21 Jefferies
Legend Biotech cilta-cel PFS rate 'largely exceeds' expectation, says Jefferies
05/28/21
Fly Intel: Top five analyst initiations
05/28/21 Morgan Stanley
Johnson & Johnson assumed with an Overweight at Morgan Stanley
05/05/21 Argus
Emergent BioSolutions downgraded to Hold from Buy at Argus
PFE Pfizer
$39.42 /

+0.28 (+0.72%)

06/01/21 Argus
Argus says market underestimating sustainability of Pfizer COVID vaccine program
05/18/21 William Blair
William Blair says continued lack of '9001 safety signals positive for Sarepta
05/12/21 Canaccord
BioNTech price target raised to $240 from $130 at Canaccord
05/11/21 SVB Leerink
BioNTech price target raised to $159 from $118 at SVB Leerink
MRK Merck
$73.44 /

-0.68 (-0.92%)

06/07/21 Truist
Merck price target lowered to $93 from $96 at Truist
05/20/21
Fly Intel: Top five analyst downgrades
05/20/21 Argus
Merck downgraded to Hold at Argus ahead of Organon spinoff
05/20/21 Argus
Merck downgraded to Hold from Buy at Argus
LLY Eli Lilly
$218.17 /

+16.055 (+7.94%)

05/27/21 H.C. Wainwright
H.C. Wainwright bullish on Dicerna as new RNAi candidate enters clinic
05/24/21 H.C. Wainwright
Aurinia reported positive data as competitors 'stumble,' says H.C. Wainwright
04/28/21 Mizuho
Eli Lilly price target lowered to $216 from $228 at Mizuho
04/28/21 Barclays
Eli Lilly price target lowered to $227 from $232 at Barclays
IMAB I-Mab
$75.98 /

-2.02 (-2.59%)

06/07/21 Piper Sandler
I-MAB price target raised to $90 from $75 at Piper Sandler
06/02/21 Daiwa
I-MAB initiated with a Buy at Daiwa
03/15/21 Needham
I-MAB initiated with a Buy at Needham
03/03/21 H.C. Wainwright
I-MAB price target raised to $75 from $55 at H.C. Wainwright
HCM Hutchmed
$30.80 /

+0.72 (+2.39%)

10/02/20 Deutsche Bank
Hutchison China MediTech initiated with a Buy at Deutsche Bank
HTBX Heat Biologics
$6.80 /

+0.355 (+5.51%)

05/06/21 Alliance Global Partners
Heat Biologics price target lowered to $32 from $40 at Alliance Global Partners
03/02/21 Cantor Fitzgerald
Heat Biologics initiated with an Overweight at Cantor Fitzgerald
02/09/21 Alliance Global Partners
Heat Biologics price target raised to $40 from $5 at Alliance Global Partners
02/09/21 Maxim
Heat data puts cancer vaccine discussion 'back on the table,' says Maxim

TODAY'S FREE FLY STORIES

Recommendations
Ryman Hospitality price target raised to $95 from $88 at Deutsche Bank » 07:07
08/05/21
08/05
07:07
08/05/21
07:07
RHP

Ryman Hospitality

$74.35 /

-2.44 (-3.18%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RHP Ryman Hospitality
$74.35 /

-2.44 (-3.18%)

07/12/21 Raymond James
Ryman Hospitality upgraded to Outperform from Market Perform at Raymond James
07/12/21 Raymond James
Ryman Hospitality upgraded to Outperform from Market Perform at Raymond James
03/18/21 Truist
Ryman Hospitality price target raised to $50 from $47 at Truist
01/12/21 Raymond James
Ryman Hospitality downgraded to Market Perform from Outperform at Raymond James
RHP Ryman Hospitality
$74.35 /

-2.44 (-3.18%)

Earnings
ViacomCBS reports Q2 adjusted EPS 97c, consensus 96c » 07:07
08/05/21
08/05
07:07
08/05/21
07:07
VIACA

ViacomCBS

$43.21 /

+0.58 (+1.36%)

, VIAC

ViacomCBS

$38.78 /

+0.31 (+0.81%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VIACA ViacomCBS
$43.21 /

+0.58 (+1.36%)

VIAC ViacomCBS
$38.78 /

+0.31 (+0.81%)

VIACA ViacomCBS
$43.21 /

+0.58 (+1.36%)

01/05/21 Gabelli
ViacomCBS named a best idea for 2021 at Gabelli
VIAC ViacomCBS
$38.78 /

+0.31 (+0.81%)

06/24/21 BofA
Comcast not pressured to make any imminent acquisition, says BofA
05/24/21 Truist
Lionsgate price target raised to $19 from $15 at Truist
05/21/21 Citi
ViacomCBS price target lowered to $54 from $56 at Citi
05/20/21
Fly Intel: Top five analyst upgrades
VIACA ViacomCBS
$43.21 /

+0.58 (+1.36%)

VIAC ViacomCBS
$38.78 /

+0.31 (+0.81%)

  • 06
    Apr
  • 29
    Mar
  • 24
    Mar
VIACA ViacomCBS
$43.21 /

+0.58 (+1.36%)

VIAC ViacomCBS
$38.78 /

+0.31 (+0.81%)

VIACA ViacomCBS
$43.21 /

+0.58 (+1.36%)

VIAC ViacomCBS
$38.78 /

+0.31 (+0.81%)

VIAC ViacomCBS
$38.78 /

+0.31 (+0.81%)

Earnings
PAE reports Q2 EPS 15c, consensus 17c » 07:07
08/05/21
08/05
07:07
08/05/21
07:07
PAE

PAE

$8.33 /

-0.3 (-3.48%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PAE PAE
$8.33 /

-0.3 (-3.48%)

PAE PAE
$8.33 /

-0.3 (-3.48%)

03/17/21 Deutsche Bank
PAE downgraded on 'unexpected' CEO change at Deutsche Bank
03/17/21 Deutsche Bank
PAE downgraded to Hold from Buy at Deutsche Bank
12/28/20 Morgan Stanley
PAE initiated with an Overweight at Morgan Stanley
PAE PAE
$8.33 /

-0.3 (-3.48%)

Earnings
Radius Health reports Q2 EPS (35c), consensus (33c) » 07:07
08/05/21
08/05
07:07
08/05/21
07:07
RDUS

Radius Health

$14.31 /

-0.28 (-1.92%)

Reports Q2 revenue $52M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDUS Radius Health
$14.31 /

-0.28 (-1.92%)

RDUS Radius Health
$14.31 /

-0.28 (-1.92%)

03/22/21 Goldman Sachs
Radius Health assumed with a Buy at Goldman Sachs
02/24/21 H.C. Wainwright
Radius Health price target raised to $25 from $22 at H.C. Wainwright
01/07/21 Citi
Radius Health price target raised to $30 from $25 at Citi
10/22/20 H.C. Wainwright
Radius Health price target lowered to $22 from $28 at H.C. Wainwright
RDUS Radius Health
$14.31 /

-0.28 (-1.92%)

Earnings
Papa John's reports Q2 EPS 93c, consensus 70c » 07:07
08/05/21
08/05
07:07
08/05/21
07:07
PZZA

Papa John's

$115.29 /

-0.62 (-0.53%)

Reports Q2 revenue $515M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PZZA Papa John's
$115.29 /

-0.62 (-0.53%)

PZZA Papa John's
$115.29 /

-0.62 (-0.53%)

08/04/21 UBS
Papa John's price target raised to $114 from $104 at UBS
08/03/21 BTIG
Papa John's price target raised to $135 from $115 at BTIG
07/19/21 Stifel
Domino's Pizza price target raised to $485 from $435 at Stifel
07/19/21 Stephens
Papa John's price target raised to $125 from $115 at Stephens
PZZA Papa John's
$115.29 /

-0.62 (-0.53%)

PZZA Papa John's
$115.29 /

-0.62 (-0.53%)

Recommendations
Arlo Technologies price target lowered to $9 from $11 at Deutsche Bank » 07:06
08/05/21
08/05
07:06
08/05/21
07:06
ARLO

Arlo Technologies

/

+

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ARLO Arlo Technologies
/

+

ARLO Arlo Technologies
/

+

02/24/21 Deutsche Bank
Arlo Technologies price target raised to $11 from $7 at Deutsche Bank
01/06/21 BWS Financial
Arlo Technologies price target raised to $10 from $8 at BWS Financial
12/01/20 Raymond James
Apple Store 'not a new channel' for Arlo Technologies, says Raymond James
09/23/20 BWS Financial
Arlo relationship with Walmart not fully realized, says BWS Financial
ARLO Arlo Technologies
/

+

Recommendations
Rapid7 price target raised to $130 from $95 at Baird » 07:06
08/05/21
08/05
07:06
08/05/21
07:06
RPD

Rapid7

$116.34 /

+0.92 (+0.80%)

Baird analyst Jonathan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RPD Rapid7
$116.34 /

+0.92 (+0.80%)

RPD Rapid7
$116.34 /

+0.92 (+0.80%)

07:01 Today Barclays
Rapid7 price target raised to $130 from $115 at Barclays
06:51 Today Mizuho
Rapid7 price target raised to $125 from $110 at Mizuho
08/02/21
Fly Intel: Top five analyst initiations
08/02/21 KeyBanc
Rapid7 initiated with an Overweight at KeyBanc
RPD Rapid7
$116.34 /

+0.92 (+0.80%)

RPD Rapid7
$116.34 /

+0.92 (+0.80%)

Hot Stocks
Chimerix announces expected upcoming milestones » 07:06
08/05/21
08/05
07:06
08/05/21
07:06
CMRX

Chimerix

$6.48 /

-0.2 (-2.99%)

Negotiation of a smallpox…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMRX Chimerix
$6.48 /

-0.2 (-2.99%)

CMRX Chimerix
$6.48 /

-0.2 (-2.99%)

06/07/21 H.C. Wainwright
Chimerix price target raised to $19 from $18 at H.C. Wainwright
05/06/21 H.C. Wainwright
Chimerix price target raised to $18 from $16 at H.C. Wainwright
04/29/21
Fly Intel: Top five analyst initiations
04/29/21 Maxim
Chimerix initiated with a Buy at Maxim
CMRX Chimerix
$6.48 /

-0.2 (-2.99%)

  • 21
    Jan
Earnings
Chimerix reports Q2 EPS (21c), consensus (19c) » 07:05
08/05/21
08/05
07:05
08/05/21
07:05
CMRX

Chimerix

$6.48 /

-0.2 (-2.99%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMRX Chimerix
$6.48 /

-0.2 (-2.99%)

CMRX Chimerix
$6.48 /

-0.2 (-2.99%)

06/07/21 H.C. Wainwright
Chimerix price target raised to $19 from $18 at H.C. Wainwright
05/06/21 H.C. Wainwright
Chimerix price target raised to $18 from $16 at H.C. Wainwright
04/29/21
Fly Intel: Top five analyst initiations
04/29/21 Maxim
Chimerix initiated with a Buy at Maxim
CMRX Chimerix
$6.48 /

-0.2 (-2.99%)

  • 21
    Jan
Earnings
Aptiv raises FY21 EPS view to $3.63-$3.87 from $3.35-$3.85, consensus $3.74 » 07:05
08/05/21
08/05
07:05
08/05/21
07:05
APTV

Aptiv

$165.66 /

-3.49 (-2.06%)

Raises FY21 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APTV Aptiv
$165.66 /

-3.49 (-2.06%)

APTV Aptiv
$165.66 /

-3.49 (-2.06%)

07/15/21 Deutsche Bank
Aptiv price target raised to $169 from $165 at Deutsche Bank
07/09/21 Jefferies
Aptiv price target raised to $182 from $170 at Jefferies
07/07/21 Barclays
Aptiv price target raised to $164 from $161 at Barclays
06/24/21 Guggenheim
Aptiv upgraded to Buy from Neutral at Guggenheim
APTV Aptiv
$165.66 /

-3.49 (-2.06%)

APTV Aptiv
$165.66 /

-3.49 (-2.06%)

APTV Aptiv
$165.66 /

-3.49 (-2.06%)

Earnings
Quotient reports Q1 EPS (24c), consensus (27c) » 07:05
08/05/21
08/05
07:05
08/05/21
07:05
QTNT

Quotient

$3.58 /

+0.16 (+4.68%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QTNT Quotient
$3.58 /

+0.16 (+4.68%)

QTNT Quotient
$3.58 /

+0.16 (+4.68%)

06/03/21 Goldman Sachs
Quotient initiated with a Neutral at Goldman Sachs
QTNT Quotient
$3.58 /

+0.16 (+4.68%)

  • 11
    Sep
QTNT Quotient
$3.58 /

+0.16 (+4.68%)

Recommendations
TechTarget price target raised to $90 from $80 at Deutsche Bank » 07:05
08/05/21
08/05
07:05
08/05/21
07:05
TTGT

TechTarget

$73.28 /

+0.63 (+0.87%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TTGT TechTarget
$73.28 /

+0.63 (+0.87%)

TTGT TechTarget
$73.28 /

+0.63 (+0.87%)

07/07/21 Sidoti
TechTarget initiated with a Buy at Sidoti
06/30/21 JPMorgan
TechTarget initiated with a Neutral at JPMorgan
06/23/21
Fly Intel: Top five analyst initiations
06/23/21 Deutsche Bank
TechTarget initiated with a Buy at Deutsche Bank
TTGT TechTarget
$73.28 /

+0.63 (+0.87%)

TTGT TechTarget
$73.28 /

+0.63 (+0.87%)

Hot Stocks
Robinhood down 11% after filing to sell up to 97.88M shares for shareholders » 07:05
08/05/21
08/05
07:05
08/05/21
07:05
HOOD

Robinhood

$70.50 /

+23.8 (+50.96%)

Robinhood shares are down…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HOOD Robinhood
$70.50 /

+23.8 (+50.96%)

HOOD Robinhood
$70.50 /

+23.8 (+50.96%)

07/29/21
Fly Intel: Top five analyst initiations
07/29/21 Atlantic Equities
Robinhood initiated with an Overweight at Atlantic Equities
  • 29
    Jul
HOOD Robinhood
$70.50 /

+23.8 (+50.96%)

HOOD Robinhood
$70.50 /

+23.8 (+50.96%)

HOOD Robinhood
$70.50 /

+23.8 (+50.96%)

Earnings
Antares Pharma sees 2021 revenue $175M-$200M, consensus $187.96M » 07:05
08/05/21
08/05
07:05
08/05/21
07:05
ATRS

Antares Pharma

$4.25 /

-0.13 (-2.97%)

The Company today…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATRS Antares Pharma
$4.25 /

-0.13 (-2.97%)

ATRS Antares Pharma
$4.25 /

-0.13 (-2.97%)

07/16/21 Truist
Truist starts Antares Pharma with Buy, $7 price target
07/16/21 Truist
Antares Pharma initiated with a Buy at Truist
ATRS Antares Pharma
$4.25 /

-0.13 (-2.97%)

Earnings
Duke Energy backs FY21 adjusted EPS view $5.00-$5.30, consensus $5.18 » 07:04
08/05/21
08/05
07:04
08/05/21
07:04
DUK

Duke Energy

$106.59 /

+ (+0.00%)

Backs long-term adjusted…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DUK Duke Energy
$106.59 /

+ (+0.00%)

DUK Duke Energy
$106.59 /

+ (+0.00%)

07/13/21 Credit Suisse
Duke Energy assumed with a Neutral at Credit Suisse
06/25/21 Argus
Duke Energy upgraded to Buy from Hold at Argus
06/17/21 RBC Capital
SC rejection a potential read-through for Duke NC IRP process, says RBC Capital
05/18/21 Morgan Stanley
Morgan Stanley sees 'low probability' Duke Energy and Elliott reach agreement
DUK Duke Energy
$106.59 /

+ (+0.00%)

DUK Duke Energy
$106.59 /

+ (+0.00%)

DUK Duke Energy
$106.59 /

+ (+0.00%)

Recommendations
Electronic Arts price target raised to $177 from $175 at Deutsche Bank » 07:04
08/05/21
08/05
07:04
08/05/21
07:04
EA

Electronic Arts

$139.79 /

+0.04 (+0.03%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

07:04 Today Baird
Electronic Arts price target raised to $170 from $160 at Baird
08/02/21 Credit Suisse
Electronic Arts price target raised to $174 from $165 at Credit Suisse
07/21/21
Fly Intel: Top five analyst upgrades
07/21/21 Deutsche Bank
Deutsche names Electronic Arts top pick in video games, upgrades to Buy
EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

Recommendations
Electronic Arts price target raised to $170 from $160 at Baird » 07:04
08/05/21
08/05
07:04
08/05/21
07:04
EA

Electronic Arts

$139.79 /

+0.04 (+0.03%)

Baird analyst Colin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

08/02/21 Credit Suisse
Electronic Arts price target raised to $174 from $165 at Credit Suisse
07/21/21
Fly Intel: Top five analyst upgrades
07/21/21 Deutsche Bank
Deutsche names Electronic Arts top pick in video games, upgrades to Buy
07/21/21 Deutsche Bank
Electronic Arts upgraded to Buy from Hold at Deutsche Bank
EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

EA Electronic Arts
$139.79 /

+0.04 (+0.03%)

Earnings
Antares Pharma reports Q2 EPS 3c, consensus 1c » 07:04
08/05/21
08/05
07:04
08/05/21
07:04
ATRS

Antares Pharma

$4.25 /

-0.13 (-2.97%)

Reports Q2 revenue $45M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATRS Antares Pharma
$4.25 /

-0.13 (-2.97%)

ATRS Antares Pharma
$4.25 /

-0.13 (-2.97%)

07/16/21 Truist
Truist starts Antares Pharma with Buy, $7 price target
07/16/21 Truist
Antares Pharma initiated with a Buy at Truist
ATRS Antares Pharma
$4.25 /

-0.13 (-2.97%)

Hot Stocks
Passage Bio expects cash balance to fund operations for next 24 months » 07:04
08/05/21
08/05
07:04
08/05/21
07:04
PASG

Passage Bio

$11.92 /

+0.07 (+0.59%)

Cash, cash equivalents…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

07/09/21 Chardan
Passage Bio coverage transferred at Chardan
07/01/21 Raymond James
Passage Bio initiated with an Outperform at Raymond James
06/30/21 Raymond James
Passage Bio initiated with an Outperform at Raymond James
06/14/21 BTIG
Passage Bio initiated with a Buy at BTIG
PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

  • 22
    Jan
Earnings
Duke Energy reports Q2 adjusted EPS $1.15, consensus $1.09 » 07:03
08/05/21
08/05
07:03
08/05/21
07:03
DUK

Duke Energy

$106.59 /

+ (+0.00%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DUK Duke Energy
$106.59 /

+ (+0.00%)

DUK Duke Energy
$106.59 /

+ (+0.00%)

07/13/21 Credit Suisse
Duke Energy assumed with a Neutral at Credit Suisse
06/25/21 Argus
Duke Energy upgraded to Buy from Hold at Argus
06/17/21 RBC Capital
SC rejection a potential read-through for Duke NC IRP process, says RBC Capital
05/18/21 Morgan Stanley
Morgan Stanley sees 'low probability' Duke Energy and Elliott reach agreement
DUK Duke Energy
$106.59 /

+ (+0.00%)

DUK Duke Energy
$106.59 /

+ (+0.00%)

DUK Duke Energy
$106.59 /

+ (+0.00%)

Recommendations
Rimini Street price target lowered to $10 from $12 at Alliance Global Partners » 07:03
08/05/21
08/05
07:03
08/05/21
07:03
RMNI

Rimini Street

$8.28 /

-0.29 (-3.38%)

Alliance Global Partners…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RMNI Rimini Street
$8.28 /

-0.29 (-3.38%)

RMNI Rimini Street
$8.28 /

-0.29 (-3.38%)

05/11/21 Roth Capital
Rimini Street downgraded to Neutral at Roth Capital
05/11/21 Roth Capital
Rimini Street downgraded to Neutral from Buy at Roth Capital
02/02/21 Craig-Hallum
Rimini Street price target raised to $11 from $6 at Craig-Hallum
02/02/21 Roth Capital
Rimini Street price target raised to $15 from $10 at Roth Capital
RMNI Rimini Street
$8.28 /

-0.29 (-3.38%)

  • 09
    Mar
  • 14
    Aug
RMNI Rimini Street
$8.28 /

-0.29 (-3.38%)

Earnings
Wayfair reports Q2 EPS $1.89, consensus $1.17 » 07:03
08/05/21
08/05
07:03
08/05/21
07:03
W

Wayfair

$251.27 /

+1.78 (+0.71%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
W Wayfair
$251.27 /

+1.78 (+0.71%)

W Wayfair
$251.27 /

+1.78 (+0.71%)

08/02/21 JPMorgan
Wayfair price target lowered to $200 from $240 at JPMorgan
07/16/21 Exane BNP Paribas
Wayfair initiated with an Outperform at Exane BNP Paribas
07/09/21 Jefferies
Wayfair price target raised to $355 from $350 at Jefferies
06/22/21 Truist
Wayfair's clearance event looks to capitalize on Prime Day effects, says Truist
W Wayfair
$251.27 /

+1.78 (+0.71%)

W Wayfair
$251.27 /

+1.78 (+0.71%)

W Wayfair
$251.27 /

+1.78 (+0.71%)

W Wayfair
$251.27 /

+1.78 (+0.71%)

Hot Stocks
Passage Bio announces anticipated upcoming milestones » 07:03
08/05/21
08/05
07:03
08/05/21
07:03
PASG

Passage Bio

$11.92 /

+0.07 (+0.59%)

Dose first patient in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

07/09/21 Chardan
Passage Bio coverage transferred at Chardan
07/01/21 Raymond James
Passage Bio initiated with an Outperform at Raymond James
06/30/21 Raymond James
Passage Bio initiated with an Outperform at Raymond James
06/14/21 BTIG
Passage Bio initiated with a Buy at BTIG
PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

  • 22
    Jan
Earnings
Passage Bio reports Q2 EPS (90c), consensus (76c) » 07:03
08/05/21
08/05
07:03
08/05/21
07:03
PASG

Passage Bio

$11.92 /

+0.07 (+0.59%)

"As we advance our…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

07/09/21 Chardan
Passage Bio coverage transferred at Chardan
07/01/21 Raymond James
Passage Bio initiated with an Outperform at Raymond James
06/30/21 Raymond James
Passage Bio initiated with an Outperform at Raymond James
06/14/21 BTIG
Passage Bio initiated with a Buy at BTIG
PASG Passage Bio
$11.92 /

+0.07 (+0.59%)

  • 22
    Jan
Earnings
Aptiv reports Q2 EPS 60c, consensus 69c » 07:03
08/05/21
08/05
07:03
08/05/21
07:03
APTV

Aptiv

$165.66 /

-3.49 (-2.06%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
APTV Aptiv
$165.66 /

-3.49 (-2.06%)

APTV Aptiv
$165.66 /

-3.49 (-2.06%)

07/15/21 Deutsche Bank
Aptiv price target raised to $169 from $165 at Deutsche Bank
07/09/21 Jefferies
Aptiv price target raised to $182 from $170 at Jefferies
07/07/21 Barclays
Aptiv price target raised to $164 from $161 at Barclays
06/24/21 Guggenheim
Aptiv upgraded to Buy from Neutral at Guggenheim
APTV Aptiv
$165.66 /

-3.49 (-2.06%)

APTV Aptiv
$165.66 /

-3.49 (-2.06%)

APTV Aptiv
$165.66 /

-3.49 (-2.06%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.